期刊
CANCER INVESTIGATION
卷 30, 期 8, 页码 571-576出版社
INFORMA HEALTHCARE
DOI: 10.3109/07357907.2012.700987
关键词
Lymphopenia; Pancreatic cancer; Immunosuppression; Chemotherapy; Radiation
类别
资金
- NCI NIH HHS [P30 CA006973] Funding Source: Medline
Fifty-three patients with resected pancreatic adenocarcinoma were studied to determine if adjuvant chemo-radiation causes severe lymphopenia and if this is associated with adverse outcomes. Total lymphocyte counts (TLC) were normal in 91% before adjuvant chemo-radiation. Two months later, TLC fell by 63% (p <. 0001) with 45% of patients having TLC < 500 cells/mm(3). Median survival in patients with low TLC was 14 versus 20 months (p = .048). Multivariate analysis revealed a significant association between treatment related lymphopenia and survival (HR 2.2, p = .014). Adjuvant chemo-radiation induced lymphopenia is frequent, severe, and an independent predictor for survival in patients with resected pancreatic adenocarcinoma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据